The paradox of scientific excellence and the search for productivity in pharmaceutical research and development

Developing the Transdisciplinary Aging Research Agenda: New Developments in Big Data

BACKGROUND

Advances in big data analytics can enable more effective and efficient research processes, with important implications for aging research. Translating these new potentialities to research outcomes, however, remains a challenge, as exponentially increasing big data availability is yet to translate into a commensurate era of 'big knowledge,' or exponential increases in biomedical breakthroughs. Some argue that big data analytics heralds a new era associated with the 'end of theory.' According to this perspective, correlation supersedes causation, and science will ultimately advance without theory and hypotheses testing. On the other hand, others argue that theory cannot be subordinate to data, no matter how comprehensive data coverage may ultimately become.

OBJECTIVE

Given these two tensions, namely (i) between exponential increases in data that have not translated into exponential increases in biomedical research outputs; and (ii) between the promise of comprehensive data coverage and inductive data-driven modes of enquiry versus theory-driven deductive modes, this critical review seeks to offer useful perspectives of big data analytics and to derive certain theoretical implications for aging research.

METHOD

This work offers a critical review of theory and literature relating big data to aging research.

RESULT

The rise of big data provides important insights into the theory development process itself, highlighting potential for holistic theoretical assemblage to ultimately enable near real time research capability.

CONCLUSION

Big data may represent a new paradigm of aging research that can dramatically increase the rate of scientific breakthroughs, but innovative theory development remains key to this potential.

Model-Informed Drug Development for Malaria Therapeutics

Malaria is a critical public health problem resulting in substantial morbidity and mortality, particularly in developing countries. Owing to the development of resistance toward current therapies, novel approaches to accelerate the development efforts of new malaria therapeutics are urgently needed. There have been significant advancements in the development of in vitro and in vivo experiments that generate data used to inform decisions about the potential merit of new compounds. A comprehensive disease-drug model capable of integrating discrete data from different preclinical and clinical components would be a valuable tool across all stages of drug development. This could have an enormous impact on the otherwise slow and resource-intensive process of traditional clinical drug development.

Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files

High-throughput screening (HTS) is an effective method for lead and probe discovery that is widely used in industry and academia to identify novel chemical matter and to initiate the drug discovery process. However, HTS can be time consuming and costly and the use of subsets as an efficient alternative to screening entire compound collections has been investigated. Subsets may be selected on the basis of chemical diversity, molecular properties, biological activity diversity or biological target focus. Previously, we described a novel form of subset screening: plate-based diversity subset (PBDS) screening, in which the screening subset is constructed by plate selection (rather than individual compound cherry-picking), using algorithms that select for compound quality and chemical diversity on a plate basis. In this paper, we describe a second-generation approach to the construction of an updated subset: PBDS2, using both plate and individual compound selection, that has an improved coverage of the chemical space of the screening file, whilst only selecting the same number of plates for screening. We describe the validation of PBDS2 and its successful use in hit and lead discovery. PBDS2 screening became the default mode of singleton (one compound per well) HTS for lead discovery in Pfizer.

Disaster management, crowdsourced R&D and probabilistic innovation theory: Toward real time disaster response capability

General agreement exists effective disaster management faces constraints related to knowledge sharing and a need for real-time research responses. Extreme case examples of disasters especially vulnerable to these challenges are global pandemics, or disease outbreaks, in which data required for research response are only available after the start of an outbreak. This paper argues the developing field of probabilistic innovation (innovation increasing probability of solving societal problems through radically increasing coordination of volumes of problem-solving inputs and analysis), and its methodologies, such as those drawing from crowdsourced R&D and social media, may offer useful insights into enabling real time research capabilities, with important implications for disaster and crisis management. Three paradigms of disaster research are differentiated, as literature is related to theory offered by post normal science, Kuhnian 'normal science' and Lakatosian 'structural science,' and the goal of achieving real time research problem solving capacity in disaster crisis situations. Global collaborative innovation platforms and large-scale investments in emerging crowdsourced R&D and social media technologies together with synthesis of appropriate theory may contribute to improved real time disaster response and resilience across contexts, particularly in instances where data required to manage response is only available after disasters unfold.